The Food and Drug Administration (FDA) recently announced a recall of three lots of Mylan nizatidine capsules because tests indicated the presence of trace amounts of N-nitrosodimethylamine (NDMA). NDMA has been classified as a probable human carcinogen and is the same chemical that has recently…
Over the last several months, e-cigarette manufacturer JUUL has faced increasing scrutiny and pressure from the U.S. government, the FDA, and the courts for its connection to the epidemic of vaping among America’s youth. The FDA has sent the company warning letters over its marketing…
In September 2019, the U.S. Food and Drug Administration (FDA) warned healthcare providers and patients that ranitidine drugs, including brand-name Zantac, had been found to contain N-nitrosodimethylamine (NDMA), a probable human carcinogen. The warning sent ripples through the healthcare community,
On December 18, 2019, the Food and Drug Administration (FDA) announced yet another generic ranitidine recall, this time implemented by Glenmark Pharmaceutical Inc. The company is pulling all prescription ranitidine tablets (150 mg and 300 mg) from the U.S. market because they may contain unacceptab
On November 4, 2019, plaintiffs involved in Zantac lawsuits filed a motion with the U.S. Judicial Panel on Multidistrict Litigation (JPML) to consolidate all federally filed Zantac lawsuits into one federal court for more efficient pre-trial proceedings. Consolidation will help preserve resources a
As JUUL Labs struggles under increasing pressure and investigations over its marketing of its e-cigarettes to minors, one of its major investors—Altria—now faces a new class-action lawsuit filed by plaintiffs who claim the company misled its investors when buying a stake in the manufacturing company
The ECRI Institute (Emergency Care Research Institute), an independent nonprofit organization focused on safe medical care, recently released its annual safety report identifying its top 10 health technology hazards for 2020. The first of the ten? Surgical stapler misuse. “Injuries and deaths from
Nine plaintiffs have jointly filed a new Zantac cancer lawsuit in the U.S. District Court for the District of New Jersey. The plaintiffs have named as defendants all Zantac manufacturers, including Boehringer Ingelheim Pharmaceuticals, Chattem Inc., GlaxoSmithKline, Pfizer, and the current manufact
A group of plaintiffs recently filed a motion with the U.S. Judicial Panel on Multidistrict Litigation (JPML) to consolidate all federally filed Zantac lawsuits into one court for pre-trial proceedings. The plaintiffs assert that all the pending actions involve common factual questions—namely, that
Following a wave of Zantac and generic ranitidine recalls, a Colorado man has filed a new Zantac lawsuit against the manufacturers of the heartburn medication. The plaintiff alleges that he used Zantac for about 23 years, and as a result, developed bladder cancer. He filed…
On July 29, 2019, JUUL Labs filed a motion with the U.S. Judicial Panel on Multidistrict Litigation (JPML) to consolidate all federally filed JUUL e-cigarette lawsuits into one court. The company noted at the time that with the increasing number of cases, consolidation was “both…
For the past few months, the Centers for Disease Control (CDC), the U.S. Food and Drug Administration (FDA), and state health departments have been investigating a mysterious vaping-related lung illness that has sent over 2,000 people to the hospital and killed at least 39. At…
